Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A

Huddle, Brandt C.; Grimley, Edward; Chtcherbinine, Mikhail; Buchman, Cameron D.; Takahashi, Cyrus; Debnath, Bikash; McGonigal, Stacy C.; Mao, Shuai; Li, Siwei; Felton, Jeremy; Pan, Shu; Wen, Bo; Sun, Duxin; Neamati, Nouri; Buckanovich, Ronald J.; Hurley, Thomas D.; Larsen, Scott D.

doi:10.1016/j.ejmech.2020.113060

Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A

Journal Article · 01 February 2021 · European Journal of Medicinal Chemistry

DOI:https://doi.org/10.1016/j.ejmech.2020.113060· OSTI ID:1763111

Huddle, Brandt C.; Grimley, Edward; Chtcherbinine, Mikhail; Buchman, Cameron D.; Takahashi, Cyrus; Debnath, Bikash; McGonigal, Stacy C.; Mao, Shuai; Li, Siwei; Felton, Jeremy; Pan, Shu; Wen, Bo; Sun, Duxin; Neamati, Nouri; Buckanovich, Ronald J.; Hurley, Thomas D.; Larsen, Scott D.

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; NCI

OSTI ID:: 1763111

Journal Information:: European Journal of Medicinal Chemistry, Vol. 211; ISSN 0223-5234

Publisher:: Elsevier

Country of Publication:: United States

Language:: ENGLISH

References (72)

Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer Magni, M.; Shammah, S.; Schiro, R. Blood, Vol. 87, Issue 3 https://doi.org/10.1182/blood.V87.3.1097.bloodjournal8731097	journal	February 1996
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen Jones, Gareth; Willett, Peter; Glen, Robert C. Journal of Molecular Biology, Vol. 267, Issue 3 https://doi.org/10.1006/jmbi.1996.0897	journal	April 1997
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition Awad, Ola; Yustein, Jason T.; Shah, Preeti PLoS ONE, Vol. 5, Issue 11 https://doi.org/10.1371/journal.pone.0013943	journal	November 2010
Lipophilic efficiency: the most important efficiency metric in medicinal chemistry Freeman-Cook, Kevin D.; Hoffman, Robert L.; Johnson, Ted W. Future Medicinal Chemistry, Vol. 5, Issue 2 https://doi.org/10.4155/fmc.12.208	journal	February 2013
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer Yokoyama, Yuhki; Zhu, Hengrui; Lee, Jeong Heon Cancer Research, Vol. 76, Issue 21 https://doi.org/10.1158/0008-5472.CAN-16-0854	journal	October 2016
PARP inhibitors: Clinical utility and possibilities of overcoming resistance Bitler, Benjamin G.; Watson, Zachary L.; Wheeler, Lindsay J. Gynecologic Oncology, Vol. 147, Issue 3 https://doi.org/10.1016/j.ygyno.2017.10.003	journal	December 2017
Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors Morgan, Cynthia A.; Hurley, Thomas D. Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm501900s	journal	February 2015
A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells Chefetz, Ilana; Grimley, Edward; Yang, Kun Cell Reports, Vol. 26, Issue 11 https://doi.org/10.1016/j.celrep.2019.02.032	journal	March 2019
Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations Ma, Stephanie; Chan, Kwok Wah; Lee, Terence Kin-Wah Molecular Cancer Research, Vol. 6, Issue 7 https://doi.org/10.1158/1541-7786.MCR-08-0035	journal	July 2008
Personalized Medicine–Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids Raghavan, Shreya; Mehta, Pooja; Ward, Maria R. Clinical Cancer Research, Vol. 23, Issue 22 https://doi.org/10.1158/1078-0432.CCR-17-0133	journal	August 2017
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells Kryczek, Ilona; Liu, Suling; Roh, Michael International Journal of Cancer, Vol. 130, Issue 1 https://doi.org/10.1002/ijc.25967	journal	April 2011
Multiple Conformations of NAD and NADH When Bound to Human Cytosolic and Mitochondrial Aldehyde Dehydrogenase ^† Hammen, Philip K.; Allali-Hassani, Abdellah; Hallenga, Klaas Biochemistry, Vol. 41, Issue 22 https://doi.org/10.1021/bi012197t	journal	June 2002
Cancer of the Ovary Cannistra, Stephen A. New England Journal of Medicine, Vol. 351, Issue 24 https://doi.org/10.1056/NEJMra041842	journal	December 2004
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors Huang, Cheng-Po; Tsai, Meng-Feng; Chang, Tzu-Hua Cancer Letters, Vol. 328, Issue 1 https://doi.org/10.1016/j.canlet.2012.08.021	journal	January 2013
Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics Dinavahi, Saketh S.; Bazewicz, Christopher G.; Gowda, Raghavendra Trends in Pharmacological Sciences, Vol. 40, Issue 10 https://doi.org/10.1016/j.tips.2019.08.002	journal	October 2019
Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD+ and retinoic acid Moretti, Andrea; Li, Jianfeng; Donini, Stefano Scientific Reports, Vol. 6, Issue 1 https://doi.org/10.1038/srep35710	journal	October 2016
Imidazo[1,2- a ]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells Quattrini, Luca; Gelardi, Edoardo Luigi Maria; Coviello, Vito Journal of Medicinal Chemistry, Vol. 63, Issue 9 https://doi.org/10.1021/acs.jmedchem.9b01910	journal	March 2020
Bevacizumab in ovarian cancer: A critical review of phase III studies Rossi, Luigi; Verrico, Monica; Zaccarelli, Eleonora Oncotarget, Vol. 8, Issue 7 https://doi.org/10.18632/oncotarget.13310	journal	November 2016
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival Silva, I. A.; Bai, S.; McLean, K. Cancer Research, Vol. 71, Issue 11 https://doi.org/10.1158/0008-5472.CAN-10-3175	journal	April 2011
Structural Basis of ALDH1A2 Inhibition by Irreversible and Reversible Small Molecule Inhibitors Chen, Yan; Zhu, Jin-Yi; Hong, Kwon Ho ACS Chemical Biology, Vol. 13, Issue 3 https://doi.org/10.1021/acschembio.7b00685	journal	December 2017
Chlorotrimethylsilane/lithium bromide and hexamethyldisilane/pyridinium bromide perbromide: effective and selective reagents for the conversion of alkyl (cycloalkyl and aralkyl) alcohols into bromides Olah, George A.; Gupta, B. G. Balaram; Malhotra, Ripudaman The Journal of Organic Chemistry, Vol. 45, Issue 9 https://doi.org/10.1021/jo01297a020	journal	April 1980
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application Koppaka, Vindhya; Thompson, David C.; Chen, Ying Pharmacological Reviews, Vol. 64, Issue 3 https://doi.org/10.1124/pr.111.005538	journal	April 2012
N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes Morgan, Cynthia A.; Parajuli, Bibek; Buchman, Cameron D. Chemico-Biological Interactions, Vol. 234 https://doi.org/10.1016/j.cbi.2014.12.008	journal	June 2015
A molecular viewer for the analysis of TLS rigid-body motion in macromolecules Painter, Jay; Merritt, Ethan A. Acta Crystallographica Section D Biological Crystallography, Vol. 61, Issue 4 https://doi.org/10.1107/S0907444905001897	journal	March 2005
ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells Moreb, Jan S.; Baker, Henry V.; Chang, Lung-Ji Molecular Cancer, Vol. 7, Issue 1 https://doi.org/10.1186/1476-4598-7-87	journal	January 2008
Discovery of novel regulators of aldehyde dehydrogenase isoenzymes Parajuli, Bibek; Kimble-Hill, Ann C.; Khanna, May Chemico-Biological Interactions, Vol. 191, Issue 1-3 https://doi.org/10.1016/j.cbi.2011.02.018	journal	May 2011
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation Jones, Gareth; Willett, Peter; Glen, Robert C. Journal of Molecular Biology, Vol. 245, Issue 1 https://doi.org/10.1016/S0022-2836(95)80037-9	journal	January 1995
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity Parajuli, Bibek; Georgiadis, Taxiarchis M.; Fishel, Melissa L. ChemBioChem, Vol. 15, Issue 5 https://doi.org/10.1002/cbic.201300625	journal	February 2014
Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB ₁ Receptor Piscitelli, Francesco; Ligresti, Alessia; La Regina, Giuseppe Journal of Medicinal Chemistry, Vol. 55, Issue 11 https://doi.org/10.1021/jm201485c	journal	May 2012
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures Saw, Yu-Ting; Yang, Junzheng; Ng, Shu-Kay BMC Cancer, Vol. 12, Issue 1 https://doi.org/10.1186/1471-2407-12-329	journal	August 2012
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells Croker, Alysha K.; Allan, Alison L. Breast Cancer Research and Treatment, Vol. 133, Issue 1 https://doi.org/10.1007/s10549-011-1692-y	journal	August 2011
FOXD1–ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells Cheng, Peng; Wang, Jia; Waghmare, Indrayani Cancer Research, Vol. 76, Issue 24 https://doi.org/10.1158/0008-5472.CAN-15-2860	journal	August 2016
Direct Reduction of Alcohols: Highly Chemoselective Reducing System for Secondary or Tertiary Alcohols Using Chlorodiphenylsilane with a Catalytic Amount of Indium Trichloride Yasuda, Makoto; Onishi, Yoshiyuki; Ueba, Masako The Journal of Organic Chemistry, Vol. 66, Issue 23 https://doi.org/10.1021/jo0158534	journal	November 2001
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity Yang, Shyh-Ming; Martinez, Natalia J.; Yasgar, Adam Journal of Medicinal Chemistry, Vol. 61, Issue 11 https://doi.org/10.1021/acs.jmedchem.8b00270	journal	May 2018
The Current Status of PARP Inhibitors in Ovarian Cancer McLachlan, Jennifer; George, Angela; Banerjee, Susana Tumori Journal, Vol. 102, Issue 5 https://doi.org/10.5301/tj.5000558	journal	September 2016
Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation. Poveda, Andres; Floquet, Anne; Ledermann, Jonathan A. Journal of Clinical Oncology, Vol. 38, Issue 15_suppl https://doi.org/10.1200/JCO.2020.38.15_suppl.6002	journal	May 2020
Combating subclonal evolution of resistant cancer phenotypes Brady, Samuel W.; McQuerry, Jasmine A.; Qiao, Yi Nature Communications, Vol. 8, Issue 1 https://doi.org/10.1038/s41467-017-01174-3	journal	November 2017
A Novel Method for the Synthesis of Imidazo[5,1- f ][1,2,4]triazin-4(3 H )-ones Heim-Riether, Alexander; Healy, Jason The Journal of Organic Chemistry, Vol. 70, Issue 18 https://doi.org/10.1021/jo051014w	journal	September 2005
Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives Buchman, Cameron D.; Hurley, Thomas D. Journal of Medicinal Chemistry, Vol. 60, Issue 6 https://doi.org/10.1021/acs.jmedchem.6b01825	journal	February 2017
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells Duong, Hong-Quan; Hwang, Jae Seok; Kim, Hee Jeong International Journal of Oncology, Vol. 41, Issue 3 https://doi.org/10.3892/ijo.2012.1516	journal	June 2012
ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway Li, Zhongjun; Xiang, Yang; Xiang, Lixin PLoS ONE, Vol. 9, Issue 3 https://doi.org/10.1371/journal.pone.0092669	journal	March 2014
ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets: ALDH ⁺ Cancer Stem Cells in Human Melanoma Luo, Yuchun; Dallaglio, Katiuscia; Chen, Ying STEM CELLS, Vol. 30, Issue 10 https://doi.org/10.1002/stem.1193	journal	September 2012
ALDH1A3, a metabolic target for cancer diagnosis and therapy: ALDH1A3 and Cancer Duan, Jiang-Jie; Cai, Jiao; Guo, Yu-Feng International Journal of Cancer, Vol. 139, Issue 5 https://doi.org/10.1002/ijc.30091	journal	April 2016
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Chou, Ting-Chao; Talalay, Paul Advances in Enzyme Regulation, Vol. 22 https://doi.org/10.1016/0065-2571(84)90007-4	journal	January 1984
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Facile reduction of malonate derivatives using NaBH4/Br2: an efficient route to 1,3-diols Tudge, Matthew; Mashima, Hiroko; Savarin, Cecile Tetrahedron Letters, Vol. 49, Issue 6 https://doi.org/10.1016/j.tetlet.2007.12.001	journal	February 2008
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy Dylla, Scott J.; Beviglia, Lucia; Park, In-Kyung PLoS ONE, Vol. 3, Issue 6 https://doi.org/10.1371/journal.pone.0002428	journal	June 2008
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2- a ]pyridines against the 1A Family Quattrini, Luca; Gelardi, Edoardo Luigi Maria; Petrarolo, Giovanni ACS Medicinal Chemistry Letters, Vol. 11, Issue 5 https://doi.org/10.1021/acsmedchemlett.9b00686	journal	March 2020
First-Line Therapy in Ovarian Cancer Trials Thigpen, Tate; duBois, Andreas; McAlpine, Jessica International Journal of Gynecologic Cancer, Vol. 21, Issue 4 https://doi.org/10.1097/IGC.0b013e31821ce75d	journal	April 2011
Bioisosterism: A Rational Approach in Drug Design Patani, George A.; LaVoie, Edmond J. Chemical Reviews, Vol. 96, Issue 8 https://doi.org/10.1021/cr950066q	journal	January 1996
Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1) Yang, Shyh-Ming; Yasgar, Adam; Miller, Bettina Journal of Medicinal Chemistry, Vol. 58, Issue 15 https://doi.org/10.1021/acs.jmedchem.5b00577	journal	July 2015
Aldehyde dehydrogenase 1A1 in stem cells and cancer Tomita, Hiroyuki; Tanaka, Kaori; Tanaka, Takuji Oncotarget, Vol. 7, Issue 10 https://doi.org/10.18632/oncotarget.6920	journal	January 2016
“Greener” Friedel−Crafts Acylations: A Metal- and Halogen-Free Methodology Wilkinson, Mark C. Organic Letters, Vol. 13, Issue 9 https://doi.org/10.1021/ol200482s	journal	May 2011
Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis Marcato, Paola; Dean, Cheryl A.; Pan, Da STEM CELLS, Vol. 29, Issue 1 https://doi.org/10.1002/stem.563	journal	January 2011
β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids Condello, S.; Morgan, C. A.; Nagdas, S. Oncogene, Vol. 34, Issue 18 https://doi.org/10.1038/onc.2014.178	journal	June 2014
Novel Azo Derivatives as Prodrugs of 5-Aminosalicylic Acid and Amino Derivatives with Potent Platelet Activating Factor Antagonist Activity Carceller, Elena; Salas, Jordi; Merlos, Manuel Journal of Medicinal Chemistry, Vol. 44, Issue 18 https://doi.org/10.1021/jm010852p	journal	August 2001
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer Landen, C. N.; Goodman, B.; Katre, A. A. Molecular Cancer Therapeutics, Vol. 9, Issue 12 https://doi.org/10.1158/1535-7163.MCT-10-0563	journal	October 2010
A Convenient Method for the Preparation of Alkyl Aryl Sulfides from Alcohols and (Chloromethylene)dimethylammonium Chloride Kawano, Yoshikazu; Kaneko, Nobuya; Mukaiyama, Teruaki Chemistry Letters, Vol. 34, Issue 12 https://doi.org/10.1246/cl.2005.1612	journal	December 2005
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Bowtell, David D.; Böhm, Steffen; Ahmed, Ahmed A. Nature Reviews Cancer, Vol. 15, Issue 11 https://doi.org/10.1038/nrc4019	journal	October 2015
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity Cortes-Dericks, Lourdes; Froment, Laurene; Boesch, Ruben BMC Cancer, Vol. 14, Issue 1 https://doi.org/10.1186/1471-2407-14-304	journal	April 2014
Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity Raghavan, Shreya; Mehta, Pooja; Horst, Eric N. Oncotarget, Vol. 7, Issue 13 https://doi.org/10.18632/oncotarget.7659	journal	February 2016
ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients Chen, Ming-Huang; Weng, Jing-Jie; Cheng, Chi-Tung Clinical Cancer Research, Vol. 22, Issue 16, p. 4225-4235 https://doi.org/10.1158/1078-0432.CCR-15-1800	journal	April 2016
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion Painter, Jay; Merritt, Ethan A. Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 4 https://doi.org/10.1107/S0907444906005270	journal	March 2006
Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance Ward Rashidi, Maria R.; Mehta, Pooja; Bregenzer, Michael Neoplasia, Vol. 21, Issue 8 https://doi.org/10.1016/j.neo.2019.06.005	journal	August 2019
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L. Journal of Chemical Information and Modeling, Vol. 50, Issue 4 https://doi.org/10.1021/ci100031x	journal	March 2010
Integrated genomic analyses of ovarian carcinoma Network, Atlas Research Nature, Vol. 474, Issue 7353, p. 609-615 https://doi.org/10.1038/nature10166	journal	June 2011
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy Huddle, Brandt C.; Grimley, Edward; Buchman, Cameron D. Journal of Medicinal Chemistry, Vol. 61, Issue 19 https://doi.org/10.1021/acs.jmedchem.8b00930	journal	May 2018
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success Lovering, Frank; Bikker, Jack; Humblet, Christine Journal of Medicinal Chemistry, Vol. 52, Issue 21 https://doi.org/10.1021/jm901241e	journal	November 2009
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study Ozols, Robert F.; Bundy, Brian N.; Greer, Benjamin E. Journal of Clinical Oncology, Vol. 21, Issue 17 https://doi.org/10.1200/JCO.2003.02.153	journal	September 2003
A physiological approach to hepatic drug clearance Wilkinson, Grant R.; Shand, David G. Clinical Pharmacology & Therapeutics, Vol. 18, Issue 4 https://doi.org/10.1002/cpt1975184377	journal	October 1975
Conformational restriction: an effective tactic in 'follow-on'-based drug discovery Fang, Zengjun; Song, Yu’ning; Zhan, Peng Future Medicinal Chemistry, Vol. 6, Issue 8 https://doi.org/10.4155/fmc.14.50	journal	May 2014
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997

Similar Records

Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)

Journal Article · 2014 · Journal of Medicinal Chemistry · OSTI ID:1093478

Axten, Jeffrey M.; Medina, Jesús R.; Feng, Yanhong; +21 more

Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa

Journal Article · 2010 · J. Med. Chem. · OSTI ID:1007607

Pinto, Donald J.P.; Orwat, Michael J; Koch, Stephanie; +11 more

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

Journal Article · 2018 · Journal of Medicinal Chemistry · OSTI ID:1484792

Huddle, Brandt C.; Grimley, Edward; Buchman, Cameron D.; +13 more

Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A

Citation Formats

References (72)

Similar Records

Related Subjects